Laboratorio Reig Jofre, S.A. (BME: RJF)

Market Cap	225.77M
Revenue (ttm)	333.69M
Net Income (ttm)	9.55M
Shares Out	80.06M
EPS (ttm)	0.12
PE Ratio	23.63
Forward PE	20.14
Dividend	0.04 (1.42%)
Ex-Dividend Date	n/a

Volume	3,696
Open	2.840
Previous Close	2.840
Day's Range	2.840 - 2.840
52-Week Range	2.150 - 3.380
Beta	0.92
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 31, 2024

About Laboratorio Reig Jofre

Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products and specialties, as well as accessories authorized foodstuffs, dietary and personal care products, and cosmetics. The company offers nutritional and parapharmacy products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; an...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1929
• Employees: 1,331
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: RJF

Financial Performance

In 2023, Laboratorio Reig Jofre's revenue was 317.95 million, an increase of 15.95% compared to the previous year's 274.21 million. Earnings were 9.41 million, an increase of 16.04%.